taining to drug abuse. All share the goal of improving treatment and prevention and the conviction that dialogue and collaboration among professional groups are essential for success.
This issue of Perspectives covers topics ranging from one of the first and still the most common of drug abuse interventions-12-step recovery programs, to one of the most innovative-antinicotine treatment with mandatory abstinence in a substance abuse treatment setting.
Our five articles and our roundtable responses contain well-grounded recommendations ranging from best clinical practices to the need for system-wide adaptation and integration.
• Greg Brigham draws attention to commonalities in the ways 12-step programs and science-based drug abuse treatments promote recovery. He submits that more research attention to 12-step programs can deepen our understanding of these processes in ways that strengthen both types of interventions. Researcher-respondents Robert Forman, Keith Humphreys, and Scott Tonigan summarize the empirical evidence on preparing patients in drug abuse therapy for successful engagement in 12-step programs after they leave treatment.
• • James Sharp and coauthors describe how they incorporated antinicotine treatment with zero tolerance for tobacco possession or use into three State-funded residential addiction treatment centers. Researchers Lirio Covey, Anne Joseph, and Steven Shoptaw praise the authors' "groundbreaking" initiative and agree that the rationale is strong for treating nicotine addiction no differently from the other addictions. However, they also judge that data are needed to answer many questions concerning which clinical antinicotine policies and interventions can yield the best overall benefits for patients during and after treatment for other addictions.
• Nancy Petry and Michael Bohn relate their experiences using low-cost incentives that reinforce drug abuse 
